interview with the Willster

[Kritters]

Yes, I'm still researching Lyme, Borrelliosis, etc....and came across this interview some of you may already have seen it...I didn't look at the date )

Lyme disease film "Under Our Skin" ノート | Facebook

Check out his closing remark:

Soon after we turned-off the camera and began packing up our gear, Dr. Burgdorfer told us with a sly smile, “I didn’t tell you everything.”

Kritts

p.s.....what do you say we take him out to dinner and get him drunk?

[Katinka]

Originally Posted by Kritters

Yes, I'm still researching Lyme, Borrelliosis, etc....and came across this interview some of you may already have seen it...I didn't look at the date )

Lyme disease film "Under Our Skin" ノート | Facebook

Check out his closing remark:

Soon after we turned-off the camera and began packing up our gear, Dr. Burgdorfer told us with a sly smile, “I didn’t tell you everything.”

Kritts

p.s.....what do you say we take him out to dinner and get him drunk?

Hey Kritts! Glad to hear you're still sticking to it! We need such people here! Yes, this Lyme Disease 'thing'..hmm..actually the docs don't really know exactly either where it comes from..but hey! maybe we are able to put a light on it? I believe 'it'..or many diseases, have something to do with environmental contaminates...a disease caused by mankind itself...hmm..
the question is...how can we stop this crazy rollercoaster?! We want to get off! We've had enough of spinning wheels..and up's and down's...

And hey! about getting that guy drunk? Bet us two could do it!!

Katinks

[hilly]

Pity they have'nt managed to do the same for humans...

June 17, 2009

http://www.intervet.com/news/2009-06...ivac-lyme.aspx



ROSELAND, New Jersey - Intervet/Schering-Plough Animal Health announced
the introduction of Nobivac(tm) Lyme. This new-generation Lyme vaccine is
the only vaccine specifically designed to provide protection by
targeting two key outer surface proteins involved in the transmission of
canine Lyme disease. The vaccine induces the production of highly
specific antibodies, called borreliacidal antibodies, that kill Borrelia
burgdorferi (the causative agent of Lyme disease) by binding to outer
surface proteins (Osp) A and C. The ability of Nobivac(tm) Lyme to
stimulate borreliacidal antibodies to both OspA and OspC significantly
differentiates this vaccine from other currently available products,
which only protect against OspA. The unique dual-action of Nobivac(tm) Lyme
provides an additional layer of defense against Lyme disease.

Nobivac Lyme is administered by giving two doses subcutaneously, two to
four weeks apart, with an annual booster thereafter. (Data supporting
one-year duration of immunity are on file with the U.S. Department of
Agriculture.) Safety studies demonstrated virtually no site reactions.

Lyme disease is due to a combination of infection with the spirochete
and the dog's immune response to the infection. Borrelia burgdorferi is
transmitted to the dog by the bite of an infected tick. Once the tick
attaches and starts taking a blood meal, the bacteria multiply in the
tick's midgut. The bacteria then migrate to the salivary glands of the
tick and enter the dog's skin at the site of attachment.

"This vaccine represents a major advance in the prevention of Lyme
disease in dogs because, unlike other Lyme vaccines on the market, it
induces OspC borreliacidal antibodies that can kill B. burgdorferi at
multiple timepoints during the infection process," said Rhonda LaFleur,
PhD. Group Leader, Biologicals Research and Development,
Intervet/Schering-Plough Animal Health. "OspA borreliacidal antibodies
only kill Borrelia while they are in the tick midgut. OspC
borreliacidal antibodies, however, kill spirochetes in the tick midgut,
spirochetes that are migrating from the midgut to the tick's salivary
glands and spirochetes that are introduced into the dog. Nobivac(tm) Lyme
thus provides more comprehensive protection for dogs."

The clinical signs of disease range from subtle lameness to high fever,
swollen lymph nodes, lameness, and loss of appetite. Rarely, a dog
infected with Lyme disease can develop severe clinical signs that, if
left untreated or treated too late, can result in permanent damage to
the heart, kidneys, nervous system and joints, or can even be fatal.

"Prevention of Lyme disease is important not only for compassionate
reasons but also because caring for sick dogs is expensive and
time-consuming," said Christopher Pappas, Jr, DVM, Director Technical
Services, Intervet/Schering-Plough Animal Health. "The new vaccine comes
at a time when reported incidences of the tick-borne illness are
increasingly common."

Ticks carrying the Lyme disease-causing bacteria have been found
throughout the United States with heavy concentrations in the Northeast,
mid-Atlantic, upper Midwest, as well as several areas on the West Coast.

NOBIVAC® is a trademark of Intervet/Schering-Plough Animal Health. This
press release contains information on a veterinary product based on
national registration dossiers and may refer to a product that is either
not available in your country or are marketed under a different
tradename. In addition, the safety and efficacy data for a specific
product may be different depending on local regulations. For more
information contact your local Intervet/Schering-Plough Animal Health
representative.

----------------------------------------------------------

.

[gigi22]

I wonder how this is different from the older vaccine? Since ticks are prevalent in our area, I thought it would be a good idea to get my dog vaccinated. My dog was so sore all over afterwards, I could not even pick her up - she would cry. I followed up and read that the vaccine could induce lyme symptoms in dogs... after that, I never had her get another one. The older vaccine was only good for one year.

[hilly]

Gigi... this vaccine does sound different.. why don't you talk to your vet about it ? I wonder if we can get it in the UK....

"This vaccine represents a major advance in the prevention of Lyme
disease in dogs because, unlike other Lyme vaccines on the market, it
induces OspC borreliacidal antibodies that can kill B. burgdorferi at
multiple timepoints during the infection process," said Rhonda LaFleur,
PhD. Group Leader, Biologicals Research and Development,
Intervet/Schering-Plough Animal Health. "OspA borreliacidal antibodies
only kill Borrelia while they are in the tick midgut. OspC
borreliacidal antibodies, however, kill spirochetes in the tick midgut,
spirochetes that are migrating from the midgut to the tick's salivary
glands and spirochetes that are introduced into the dog. Nobivac(tm) Lyme
thus provides more comprehensive protection for dogs."

[gigi22]

Hilly -

I thought through this, and I came to the conclusion that my dog's risk of contracting lyme is low compared to the risks of the side effects for the vaccine. Plus, with it being a new vaccine, we have no idea the long term effects of this. Sounds great in theory, though. I do get her the required vax (rabies, DHPP, etc) because we board her at times. She is mainly an indoor dog, and occasionally will be let out in the back yard to roam in the fenced-in area... except now that the ticks are out... I won't let her outside! Hubby thought I was going overboard, until the pup came in with a tick climbing on her fur and I made him get it off.
So, now, she's not allowed out in the yard until we can get something done about the ticks.